An investigational Alzheimer's drug reduced molecular markers of disease and curbed neurodegeneration in the brain, without demonstrating evidence of cognitive benefit, in a clinical trial
from Medindia Health News https://ift.tt/3cZRwoN
No comments:
Post a Comment